About: http://data.cimple.eu/news-article/40f9b4dd0d90695c6e153c9ca103afb07597ebefc2ca4ec3cfe80573

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/40f9b4dd0d90695c6e153c9ca103afb07597ebefc2ca4ec3cfe80573 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	India on Tuesday authorised the emergency use of Moderna's Covid-19 vaccine as it seeks to ramp up its vaccination drive in the wake of a record-breaking surge in infections and deaths. The vast nation of 1.3 billion people was hit by a massive spike in coronavirus cases in April and May that pushed the healthcare system to breaking point. Moderna's shot is the fourth to be approved by New Delhi after Oxford-AstraZeneca's Covishield and Covaxin, which was developed by Indian firm Bharat Biotech, and Russia's Sputnik V. "I am pleased to inform that an application received from Moderna through an Indian partner of theirs, Cipla, has been granted EUA (Emergency Use Authorisation)," a member of government advisory body NITI Aayog, Vinod K. Paul, said at a health ministry briefing. "Our efforts to invite and to have other internationally developed vaccines, specifically Pfizer and J&J (Johnson & Johnson), also continue." Paul added that the approval would pave the way for other foreign-made vaccines to be imported into India. A small number of Sputnik V shots have imported into India after the drug was granted approval in mid-April, but the majority are expected to be manufactured within the country, like Covishield and Covaxin. India said two months ago that it would fast-track the approval of vaccines manufactured outside the country that have already been granted emergency use authorisation by major regulators such as the US Food and Drug Administration. The government had been under pressure to speed up its flagging inoculation drive by allowing the import of foreign-made vaccines such as mRNA vaccines Pfizer and Moderna. Nearly 327 million doses have been administered since the mass vaccination programme kicked off in mid-January. But just six percent of India's adult population -- or 57 million people -- have received both doses of a two-shot regime. India is the world's second-most infected nation with more than 30 million cases and nearly 398,000 deaths. bb-grk/jfx
schema:headline	India approves Moderna's Covid-19 vaccine for emergency use
schema:mentions	Cipla Smallpox vaccine Johnson & Johnson Sputnik 1 New Delhi Messenger RNA Russia Pfizer India Vaccine Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Vinod Khosla NITI Aayog
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-06-29 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	79 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software